Diagnostics News and Research

RSS

BioDiscovery, Affymetrix enter co-marketing agreement for OncoScan FFPE Express Service

Affymetrix, Inc. today announced a co-marketing agreement naming BioDiscovery, Inc. its preferred software provider for Affymetrix OncoScan FFPE Express Service data analysis.

27 May 2011

'Spongy' silicon biosensor shows promise for medical, security applications

Vanderbilt University engineers have created a "spongy" silicon biosensor that shows promise not only for medical diagnostics, but also for the detection of dangerous toxins and other tiny molecules in the environment.

27 May 2011

Biosign to demonstrate latest generation medical measurement system at International MeMeA symposium

Biosign Technologies Inc. announced today that it will introduce its latest generation medical measurement system, the UFIT TEN-20, at the International Symposium on Medical Measurements and Applications, being held in Italy by the Institute of Electrical and Electronics Engineers on May 30-31, 2011. Dr Radu Leca, Biosign's CEO, will speak and demonstrate the system during the Plenary Session - Invited Lecture "Issues in Medical Measurement".

27 May 2011

Mold and ragweed allergies on the rise in the U.S.

Allergies are on the rise and it is noted that more numbers of Americans sensitive to ragweed and mold. Phoenix, Las Vegas and the Riverside-San Bernardino area are among the 30 worst affected areas with this allergy.

26 May 2011

Medicago, USAMRIID enter research collaboration for Ebola vaccine candidate

Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into a research collaboration agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for the development of a plant-based VLP vaccine candidate for the prevention of Ebola. Ebola is a very serious hemorrhagic fever virus for which no licensed treatment or vaccine exists.

26 May 2011

Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASCO 2011

Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.

26 May 2011

AIBioTech works with U.S. FDA to keep Sports X Factor genetic test available to consumers

American International Biotechnology Services today announced it is working with the U.S. Food and Drug Administration to keep its Sports X Factor genetic test available to consumers.

26 May 2011

Recent advances in vaccine development for malaria, TB and HIV/AIDS

Collectively, malaria, TB & HIV/AIDS cause more than five million deaths per year - nearly the entire population of the state of Washington - and represent one of the world's major public health challenges as we move into the second decade of the 21st century.

26 May 2011

GE Healthcare receives FDA 510k clearance for CoreScan to treat obesity-related disease

GE Healthcare today announced 510k clearance of CoreScan - a widely-accessible application dedicated to quickly and accurately quantifying visceral adipose tissue, or visceral "belly" fat, during body composition analysis.

26 May 2011

Elan, Proteostasis create innovative drug discovery initiative for neurodegenerative disorders

Proteostasis Therapeutics and Elan Corporation today announced a strategic business relationship to advance Proteostasis' platform for the discovery and development of disease-modifying, small molecule drugs and diagnostics for the treatment of neurodegenerative disorders such as Parkinson's, Huntington's, multiple sclerosis and amyotrophic lateral sclerosis, and a broad array of dementia-related diseases including Alzheimer's.

25 May 2011

Vectra DA blood test may help predict patients' response to rheumatoid arthritis therapy

Crescendo Bioscience- today announced data indicating that Vectra- DA, a first-in-class multi-biomarker blood test used to assess rheumatoid arthritis disease activity, provides physicians with an objective measure which may help determine whether patients are responding to therapy.

25 May 2011

MIT, ADI partner to research and develop technologies for next-generation patient monitoring devices

Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.

25 May 2011

Positive preliminary results from Genomic Health's Oncotype DX study in DCIS breast cancer

Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.

25 May 2011

MIT, GE partner to create Medical Electronic Device Realization Center

Supporting its quest through healthymagination to reach more patients with better health care globally, GE has joined with the Massachusetts Institute of Technology (MIT) to create a Medical Electronic Device Realization Center at MIT.

25 May 2011

FDA approves Abbott's XIENCE nano stent for treatment of coronary artery disease in small vessels

Abbott today announced it has received U.S. Food and Drug Administration approval for the XIENCE nano Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease in small vessels.

25 May 2011

LinkMed acquires NorDiag's 50% stake in Olerup International

LinkMed acquires NorDiag´s 50 percent stake in Olerup International AB, which is the holding company for Olerup GmbH. LinkMed will thereby control 75 percent of the company.

24 May 2011

Exosome Diagnostics announces expansion of scientific advisory board

Exosome Diagnostics, a leading developer of biofluid based molecular diagnostic tests for use in personalised medicine, today announced the appointments of Bob Carter MD, Carlos Cordon-Cardo MD, PhD, Keith Flaherty MD, John Quackenbush, PhD; to its Scientific Advisory Board (SAB).

24 May 2011

Nestle Health Science to acquire Prometheus Laboratories

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced that it has entered into a definitive agreement to be acquired by Nestle Health Science S.A., a wholly-owned subsidiary of Nestle S.A., for an undisclosed amount.

24 May 2011

Boston Healthcare announces acquisition of Alpha Care

Boston Healthcare announced today that it has acquired Alpha Care GmbH, a consulting firm based in Germany that provides health economics and policy solutions for pharmaceutical, medical device, payer and provider organizations.

23 May 2011

Roche's new cobas TaqScreen MPX viral discriminatory test, v2.0 now available in Europe

Roche announced today that the cobas TaqScreen MPX Test, version 2.0 for use on the cobas s 201 system is now commercially available in Europe.

23 May 2011

Diagnostics News and Research

BioDiscovery, Affymetrix enter co-marketing agreement for OncoScan FFPE Express Service

'Spongy' silicon biosensor shows promise for medical, security applications

Biosign to demonstrate latest generation medical measurement system at International MeMeA symposium

Mold and ragweed allergies on the rise in the U.S.

Medicago, USAMRIID enter research collaboration for Ebola vaccine candidate

Boehringer Ingelheim's new afatinib-cetuximab phase Ib data in NSCLC presented at ASCO 2011

AIBioTech works with U.S. FDA to keep Sports X Factor genetic test available to consumers

Recent advances in vaccine development for malaria, TB and HIV/AIDS

GE Healthcare receives FDA 510k clearance for CoreScan to treat obesity-related disease

Elan, Proteostasis create innovative drug discovery initiative for neurodegenerative disorders

Vectra DA blood test may help predict patients' response to rheumatoid arthritis therapy

MIT, ADI partner to research and develop technologies for next-generation patient monitoring devices

Positive preliminary results from Genomic Health's Oncotype DX study in DCIS breast cancer

MIT, GE partner to create Medical Electronic Device Realization Center

FDA approves Abbott's XIENCE nano stent for treatment of coronary artery disease in small vessels

LinkMed acquires NorDiag's 50% stake in Olerup International

Exosome Diagnostics announces expansion of scientific advisory board

Nestle Health Science to acquire Prometheus Laboratories

Boston Healthcare announces acquisition of Alpha Care

Roche's new cobas TaqScreen MPX viral discriminatory test, v2.0 now available in Europe

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News